1. AstraZeneca and Amgen get optimistic phase 3 asthma drug results — Pfizer/BioNTech begin studies for third booster dose and development of vaccine for variants — Merck KGaA in biobucks pact with Debiopharm for next-gen cancer asset See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    On acquaintance of mine recently approached me asking for 340 B pricing on various medical supplies. My question is: Would it be legal for me to broker that deal?